With changing lifestyles, non-alcoholic fatty liver disease (NAFLD) has become the most
prevalent liver disease worldwide. A substantial increase in the incidence, mortality, and …

Aim With industrialization and spread of the westernized lifestyle, the number of people
affected by non‐alcoholic fatty liver disease (NAFLD)/non‐alcoholic steatohepatitis (NASH) …

Non-alcoholic fatty liver disease (NAFLD) has now become the leading chronic liver disease
worldwide with lifestyle changes. This may lead to NAFLD becoming the leading cause of …

Introduction Non-alcoholic fatty liver disease (NAFLD), a major cause of chronic liver
disease, still lacks effective therapeutic targets today. Ferroptosis, a type of cell death …

Many studies have confirmed the effectiveness of herbal medicines or complex formulations
in clinical therapy for metabolic diseases. This study investigated the effects of a HeShouWu …

SARS-CoV-2—severe acute respiratory syndrome coronavirus 2; MetS—metabolic
syndrome; DMT2—diabetes mellitus type 2; MAFLD—metabolic-associated fatty liver …

Aims Nonalcoholic steatohepatitis (NASH) is becoming one of the most common causes of
liver transplantation and hepatocellular carcinoma, but no specific drugs are FDA-approved …

Introduction Berberine (BBR) is an alkaloid found in plants. It has neuroprotective, anti‐
inflammatory and lipid‐lowering activity. However, the efficacy of treatment with BBR and the …

Hepatocellular carcinoma (HCC) is a common cancer which unfortunately has poor
outcomes. Common anti-cancer treatments such as chemotherapy and targeted therapy …

Accumulating evidence suggests that berberine (BBR) exhibits anti‐cancer effects in
hepatocellular carcinoma (HCC). However, the mechanisms by which BBR regulates the …